Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Humanized Antibody
1.2.3 Human Mouse Chimeric Antibody
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infection
1.3.5 Hematological Diseases
1.3.6 Ophthalmological Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Therapeutics Market Perspective (2018-2033)
2.2 Monoclonal Antibody Therapeutics Growth Trends by Region
2.2.1 Global Monoclonal Antibody Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Monoclonal Antibody Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Monoclonal Antibody Therapeutics Market Dynamics
2.3.1 Monoclonal Antibody Therapeutics Industry Trends
2.3.2 Monoclonal Antibody Therapeutics Market Drivers
2.3.3 Monoclonal Antibody Therapeutics Market Challenges
2.3.4 Monoclonal Antibody Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue
3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue
3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2022
3.5 Monoclonal Antibody Therapeutics Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Therapeutics Breakdown Data by Type
4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2024-2033)
5 Monoclonal Antibody Therapeutics Breakdown Data by Application
5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Monoclonal Antibody Therapeutics Market Size (2018-2033)
6.2 North America Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Monoclonal Antibody Therapeutics Market Size by Country (2018-2023)
6.4 North America Monoclonal Antibody Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Therapeutics Market Size (2018-2033)
7.2 Europe Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Monoclonal Antibody Therapeutics Market Size by Country (2018-2023)
7.4 Europe Monoclonal Antibody Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Therapeutics Market Size (2018-2033)
9.2 Latin America Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Monoclonal Antibody Therapeutics Introduction
11.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction
11.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction
11.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Monoclonal Antibody Therapeutics Introduction
11.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Therapeutics Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.8.5 AbbVie Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Monoclonal Antibody Therapeutics Introduction
11.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.9.5 Amgen Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.10.5 Johnson & Johnson Recent Development
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Detail
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.11.5 Bristol-Myers Squibb Company Recent Development
11.12 Biogen
11.12.1 Biogen Company Detail
11.12.2 Biogen Business Overview
11.12.3 Biogen Monoclonal Antibody Therapeutics Introduction
11.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2018-2023)
11.12.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Humanized Antibody
Table 3. Key Players of Human Mouse Chimeric Antibody
Table 4. Global Monoclonal Antibody Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Monoclonal Antibody Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Monoclonal Antibody Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Monoclonal Antibody Therapeutics Market Share by Region (2018-2023)
Table 8. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Monoclonal Antibody Therapeutics Market Share by Region (2024-2033)
Table 10. Monoclonal Antibody Therapeutics Market Trends
Table 11. Monoclonal Antibody Therapeutics Market Drivers
Table 12. Monoclonal Antibody Therapeutics Market Challenges
Table 13. Monoclonal Antibody Therapeutics Market Restraints
Table 14. Global Monoclonal Antibody Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Monoclonal Antibody Therapeutics Market Share by Players (2018-2023)
Table 16. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2022)
Table 17. Ranking of Global Top Monoclonal Antibody Therapeutics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Monoclonal Antibody Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Monoclonal Antibody Therapeutics Product Solution and Service
Table 21. Date of Enter into Monoclonal Antibody Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Monoclonal Antibody Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2024-2033)
Table 27. Global Monoclonal Antibody Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2018-2023)
Table 29. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2024-2033)
Table 31. North America Monoclonal Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Monoclonal Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Monoclonal Antibody Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Monoclonal Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Monoclonal Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Monoclonal Antibody Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Monoclonal Antibody Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Monoclonal Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Bayer Company Detail
Table 47. Bayer Business Overview
Table 48. Bayer Monoclonal Antibody Therapeutics Product
Table 49. Bayer Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 50. Bayer Recent Development
Table 51. F. Hoffmann-La Roche Company Detail
Table 52. F. Hoffmann-La Roche Business Overview
Table 53. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product
Table 54. F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 55. F. Hoffmann-La Roche Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Monoclonal Antibody Therapeutics Product
Table 59. Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Sanofi Company Detail
Table 62. Sanofi Business Overview
Table 63. Sanofi Monoclonal Antibody Therapeutics Product
Table 64. Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Monoclonal Antibody Therapeutics Product
Table 69. GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Merck Company Detail
Table 72. Merck Business Overview
Table 73. Merck Monoclonal Antibody Therapeutics Product
Table 74. Merck Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Novartis Company Detail
Table 77. Novartis Business Overview
Table 78. Novartis Monoclonal Antibody Therapeutics Product
Table 79. Novartis Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. AbbVie Company Detail
Table 82. AbbVie Business Overview
Table 83. AbbVie Monoclonal Antibody Therapeutics Product
Table 84. AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 85. AbbVie Recent Development
Table 86. Amgen Company Detail
Table 87. Amgen Business Overview
Table 88. Amgen Monoclonal Antibody Therapeutics Product
Table 89. Amgen Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 90. Amgen Recent Development
Table 91. Johnson & Johnson Company Detail
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Monoclonal Antibody Therapeutics Product
Table 94. Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 95. Johnson & Johnson Recent Development
Table 96. Bristol-Myers Squibb Company Company Detail
Table 97. Bristol-Myers Squibb Company Business Overview
Table 98. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product
Table 99. Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 100. Bristol-Myers Squibb Company Recent Development
Table 101. Biogen Company Detail
Table 102. Biogen Business Overview
Table 103. Biogen Monoclonal Antibody Therapeutics Product
Table 104. Biogen Revenue in Monoclonal Antibody Therapeutics Business (2018-2023) & (US$ Million)
Table 105. Biogen Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Monoclonal Antibody Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Humanized Antibody Features
Figure 4. Human Mouse Chimeric Antibody Features
Figure 5. Global Monoclonal Antibody Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Monoclonal Antibody Therapeutics Market Share by Application: 2022 VS 2033
Figure 7. Cancer Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Infection Case Studies
Figure 10. Hematological Diseases Case Studies
Figure 11. Ophthalmological Diseases Case Studies
Figure 12. Others Case Studies
Figure 13. Monoclonal Antibody Therapeutics Report Years Considered
Figure 14. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Monoclonal Antibody Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Monoclonal Antibody Therapeutics Market Share by Region: 2022 VS 2033
Figure 17. Global Monoclonal Antibody Therapeutics Market Share by Players in 2022
Figure 18. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2022
Figure 20. North America Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Monoclonal Antibody Therapeutics Market Share by Country (2018-2033)
Figure 22. United States Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Monoclonal Antibody Therapeutics Market Share by Country (2018-2033)
Figure 26. Germany Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Region (2018-2033)
Figure 34. China Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Monoclonal Antibody Therapeutics Market Share by Country (2018-2033)
Figure 42. Mexico Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Country (2018-2033)
Figure 46. Turkey Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Monoclonal Antibody Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 49. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 53. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 55. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 56. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 58. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 59. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed